MOLECULAR MECHANISMS OF ACQUIRED RESISTANCE TO KINASE INHIBITORS

被引：0
|
作者：
Sequist, L. V. [1 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] MOLECULAR MECHANISMS OF ACQUIRED RESISTANCE TO EGFR TYROSINE KINASE INHIBITORS IN GBM
    Wykosky, Jill
    Cavenee, Webster
    Furnari, Frank
    NEURO-ONCOLOGY, 2011, 13 : 16 - 16
  • [2] Mechanisms of acquired resistance to tyrosine kinase inhibitors
    Chen, Yi-fan
    Fu, Li-wu
    ACTA PHARMACEUTICA SINICA B, 2011, 1 (04) : 197 - 207
  • [3] Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors
    Yaghmaie, Marjan
    Yeung, Cecilia C. S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (05) : 395 - 404
  • [4] Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors
    Marjan Yaghmaie
    Cecilia CS Yeung
    Current Hematologic Malignancy Reports, 2019, 14 : 395 - 404
  • [5] Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
    J. Rafael Sierra
    Virna Cepero
    Silvia Giordano
    Molecular Cancer, 9
  • [6] Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
    Sierra, J. Rafael
    Cepero, Virna
    Giordano, Silvia
    MOLECULAR CANCER, 2010, 9
  • [7] Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers
    Hofmann, Marie-Claude
    Kunnimalaiyaan, Muthusamy
    Wang, Jennifer R.
    Busaidy, Naifa L.
    Sherman, Steven, I
    Lai, Stephen Y.
    Zafereo, Mark
    Cabanillas, Maria E.
    ENDOCRINE-RELATED CANCER, 2022, 29 (11) : R173 - R190
  • [8] Characterization of Acquired Receptor Tyrosine Kinase Fusions as Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors
    Xu, H.
    Shu, Y.
    Jian, H.
    Shen, J.
    Xiang, J.
    Li, H.
    Li, B.
    Zhang, T.
    Zhang, L.
    Mao, X.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S562 - S563
  • [9] Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC
    Recondo, Gonzalo
    Bahcall, Magda
    Spurr, Liam F.
    Che, Jianwei
    Ricciuti, Biagio
    Leonardi, Giulia C.
    Lo, Ying-Chun
    Li, Yvonne Y.
    Lamberti, Giuseppe
    Nguyen, Tom
    Milan, Marina S. D.
    Venkatraman, Deepti
    Umeton, Renato
    Paweletz, Cloud P.
    Albayrak, Adem
    Cherniack, Andrew D.
    Price, Kristin S.
    Fairclough, Stephen R.
    Nishino, Mizuki
    Sholl, Lynette M.
    Oxnard, Geoffrey R.
    Janne, Pasi A.
    Awad, Mark M.
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 2615 - 2625
  • [10] Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma
    Tian, Yichen
    Lei, Yongrong
    Fu, Yuna
    Sun, Heng
    Wang, Jianhua
    Xia, Feng
    CURRENT CANCER DRUG TARGETS, 2022, 22 (06) : 454 - 462
12345